Get started
666

CALIWAY BIOPHARMACEUTICALS CO LTD

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

6919 chart


Full chart

6919 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪78.70 B‬ TWD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−488.45 M‬ TWD
Revenue (FY)
‪38.93 M‬ TWD
Shares float
‪120.46 M‬
Beta (1Y)
1.14

Employees


Employees (FY)
41
Revenue / Employee (1Y)
‪30.93 K‬ TWD
Net income / Employee (1Y)
‪−388.07 K‬ TWD

About CALIWAY BIOPHARMACEUTICALS CO LTD


Sector
Health Technology
Industry
Biotechnology
CEO
Vivian Ling
Website
caliway.com.tw
Headquarters
New Taipei City
Founded
2012
ISIN
TW0006919004
FIGI
BBG01C1NTWH0
Caliway Biopharmaceuticals Co. Ltd. offers pharmaceutical services. It focuses on medical aesthetics and inflammatory medicine discovery of small-molecule therapeutics to help patients suffering from illness or life threatening diseases. The company was founded in 2012 and is headquartered in New Taipei City, Taiwan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

6919 news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 6919 is 529 TWD — it has increased by 4.68% in the past 24 hours. Watch CALIWAY BIOPHARMACEUTICALS CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange CALIWAY BIOPHARMACEUTICALS CO LTD stocks are traded under the ticker 6919.
6919 stock has fallen by −0.37% compared to the previous week, the month change is a 11.88% rise, over the last year CALIWAY BIOPHARMACEUTICALS CO LTD has showed a −1.31% decrease.
We've gathered analysts' opinions on CALIWAY BIOPHARMACEUTICALS CO LTD future price: according to them, 6919 price has a max estimate of 735.00 TWD and a min estimate of 680.00 TWD. Watch 6919 chart and read a more detailed CALIWAY BIOPHARMACEUTICALS CO LTD stock forecast: see what analysts think of CALIWAY BIOPHARMACEUTICALS CO LTD and suggest that you do with its stocks.
6919 reached its all-time high on Nov 4, 2024 with the price of 553 TWD, and its all-time low was 436 TWD and was reached on Oct 16, 2024. View more price dynamics on 6919 chart.
See other stocks reaching their highest and lowest prices.
6919 stock is 3.44% volatile and has beta coefficient of 1.14. Track CALIWAY BIOPHARMACEUTICALS CO LTD stock price on the chart and check out the list of the most volatile stocks — is CALIWAY BIOPHARMACEUTICALS CO LTD there?
Today CALIWAY BIOPHARMACEUTICALS CO LTD has the market capitalization of ‪82.40 B‬, it has increased by 5.09% over the last week.
Yes, you can track CALIWAY BIOPHARMACEUTICALS CO LTD financials in yearly and quarterly reports right on TradingView.
CALIWAY BIOPHARMACEUTICALS CO LTD is going to release the next earnings report on Apr 10, 2025. Keep track of upcoming events with our Earnings Calendar.
6919 earnings for the last quarter are −1.32 TWD per share, whereas the estimation was −1.31 TWD resulting in a −1.09% surprise. The estimated earnings for the next quarter are −1.30 TWD per share. See more details about CALIWAY BIOPHARMACEUTICALS CO LTD earnings.
CALIWAY BIOPHARMACEUTICALS CO LTD revenue for the last quarter amounts to ‪12.00 M‬ TWD, despite the estimated figure of ‪12.00 M‬ TWD. In the next quarter, revenue is expected to reach ‪12.50 M‬ TWD.
6919 net income for the last quarter is ‪−137.57 M‬ TWD, while the quarter before that showed ‪−176.65 M‬ TWD of net income which accounts for 22.12% change. Track more CALIWAY BIOPHARMACEUTICALS CO LTD financial stats to get the full picture.
No, 6919 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 41.00 employees. See our rating of the largest employees — is CALIWAY BIOPHARMACEUTICALS CO LTD on this list?
Like other stocks, 6919 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CALIWAY BIOPHARMACEUTICALS CO LTD stock right from TradingView charts — choose your broker and connect to your account.